These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6521166)

  • 1. [Factors causing chronic tubercle bacilli excreters].
    Yamaguchi T
    Kekkaku; 1984 Oct; 59(10):544-7. PubMed ID: 6521166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monotherapy of chronic pulmonary tuberculosis using Rimactan. Report on a 3-month-long therapeutic series].
    Hofmann F
    Schweiz Med Wochenschr; 1968 Sep; 98(36):1363-7. PubMed ID: 4971389
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin in chronic pulmonary tuberculosis].
    Levit T; Terracina S; Karman S
    Harefuah; 1971 Jun; 80(11):604-6. PubMed ID: 5157984
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidemiological studies on the infectivity of chronic tubercle bacilli excreters].
    Saito M
    Kekkaku; 1984 Oct; 59(10):542-4. PubMed ID: 6521165
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin in the treatment of pulmonary tuberculosis].
    Bumbăcescu N; Ionescu C
    Ftiziologia; 1971; 20(6):619-22. PubMed ID: 5162288
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lung function in chronic tubercle bacilli excreters].
    Imura Y
    Kekkaku; 1984 Oct; 59(10):556-9. PubMed ID: 6521170
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on causes of death in chronic tubercle bacilli excreters].
    Hirasawa I
    Kekkaku; 1984 Oct; 59(10):547-50. PubMed ID: 6521167
    [No Abstract]   [Full Text] [Related]  

  • 8. [Must duration of treatment of tuberculosis be modified since utilization of rifampicine? Is prolonged rest always necessary?].
    Despierres G; Bonnet PA; Phelip H; Bonnet
    Lyon Med; 1970 Oct; 224(34):397-400. PubMed ID: 4991510
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 10. [Resumption of treatment by rifomycin of resistant cases of pulmonary tuberculosis].
    Destexhe GE
    Acta Tuberc Pneumol Belg; 1969; 60(3):501-6. PubMed ID: 5371674
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with the use of rifampicin (rimactan) in patients with chronic destructive forms of pulmonary tuberculosis].
    Ginzburg ZI
    Probl Tuberk; 1971; 49(12):77-8. PubMed ID: 5145746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and radiological results of rifampicin therapy in chronic pulmonary tuberculosis].
    Merenda P
    G Ital Mal Torace; 1969; ():Suppl 2:105-6. PubMed ID: 5357132
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of rifampicin (R-AMP) in chronic pulmonary tuberculosis].
    Casalone G; Giura R; Lusco G
    G Ital Mal Torace; 1968; 22(4):215-8. PubMed ID: 5743003
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surgical treatment for chronic tubercle bacilli excreters].
    Yanai N
    Kekkaku; 1984 Oct; 59(10):553-6. PubMed ID: 6521169
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic patients from Zemun treated with Rifadin].
    Simić B; Burmaz Z
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():116-20. PubMed ID: 4614292
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistant mycobacterium tuberculosis: report of a family in Connecticut.
    Gerstenhaber BJ
    Conn Med; 1980 Jul; 44(7):416-8. PubMed ID: 6772373
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin].
    Baba H
    Kekkaku; 1994 Jun; 69(6):387-96. PubMed ID: 8041057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin in chronic polyresistant cases of pulmonary tuberculosis.
    Meissner G
    Acta Tuberc Pneumol Belg; 1969; 60(3):482-6. PubMed ID: 5371673
    [No Abstract]   [Full Text] [Related]  

  • 20. Twenty-year trend of chronic excretors of tubercle bacilli based on the nationwide tuberculosis prevalence surveys in Korea, 1975-1995.
    Hong YP; Kim SJ; Bai JY; Lew WJ; Lee EG
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):911-9. PubMed ID: 11055757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.